Sponsored research and the public's right to know

Drug Development Research

Volumn 63, Issue 3, 2004, Pages 103-111

  Fersko, Raymond S ^a   Merabet, Hind ^a  

^a Ferskos LLC   (United States)

Author keywords

Dissemination of research data; Financial conflicts of interest; Public interest; Stem cells; Technology transfer

Indexed keywords

EMBRYONIC STEM CELL; ETHICS; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE POLICY; MEDICAL RESEARCH; REVIEW; TECHNOLOGY;

EID: 16444362814     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10408     Document Type: Review

References (67)

1. Associated Press. 2004. New Jersey set to fund stem cell research. USA Today. February 22 (available at http://www.usatoday.com/news/science/2004-02- 22-stem-cell-research_x.htm).
2. Association of American Medical Colleges (AAMC). 2004. Clinical trial contracts: a discussion of four selected provisions. (available at http://www.aamc.org/publications/clinicaltrial.htm).
3. Association of University Technology Managers (AUTM). 2003. Licensing survey: FY 2002. A survey summary of technology licensing and related performance for U.S. and Canadian academic and nonprofit institutions, and patent management and investment firms. (available at http://www.autm.net/ index_ie.html).
4. Association of University Technology Managers (AUTM). 2003. Technology transfer practice manual, Volume III.
5. Ballas CB, Zielske SP, Gerson SL. 2002. Adult bone marrow stem cells for cell and gene therapies: implications for greater use. J Cell Biochem 38(Suppl):20-28.
6. Balint JA. 2002. Ethical issues in stem cell research. Alb L Rev 65:729-742.
7. BBC News. 2004. Millions for stem cells. May 27. (available at http://news.bbc:co.uk/1/hi/health/3752651.stm).
8. Bekelman JE, Li Y. Gross CP. 2003. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. J Am Med Assoc 289:454-465.
9. Blumenthal D. 2003. Academic-industrial relationships in the life sciences. N Engl J Med 349:2452-2459.
10. Blumentlial D, Causino N, Campbell E, Louis KS. 1996a. Relationships between academic institutions and industry in the life sciences - an industry survey. N Engl J Med 334:368-373.
11. Blumenthal D, Campbell EG, Causino N, Louis KS. 1996b. Participation of life-science faculty in research relationships with industry. N Engl J Med 335:1734-1739.
12. Bok D. 2003. Universities in the marketplace. Princeton, NJ: Princeton University Press. p 22.
13. Bulger RE, Meyer Bobby E, Harvey V, Editors. 1995. Society's choices: social and ethical decision making in biomedicine. Institute of Medicine. National Academy Press, Washington, DC, 560 p.
14. Cantekin EI, McGuire TW, Potter RL. 1990. Biomedical information, peer review, and conflict of interest as they influence public health. J Am Med Assoc. 264:3144-3145.
15. Cho DK. 2003. The journey of Taxol. J Biolaw Bus Bio-Education Special Supplement 49-64.
16. Cho MK, Shohara R., Schissel A., Rennie D. Policies on faculty conflicts of interest at US Universities. 2000. J Am Med Assoc 1:284:2203-2208.
17. Condic ML. 2002. Stem cells and false hopes. First Things 125:21-22.
18. Cook G. 2004. US stem cell research lagging without aid, work moving overseas. The Boston Globe, May 23. (available at http://www.boston.com/news/ world/articles/2004/05/23/us_stem_cell_research_lagging?pg=full).
19. Cooper CP, Yukimura D. 2002. Science writer's reactions to a medical "breakthrough" story. Soc Sci Med 54:1887-1896.
20. De Angelis CD. 2000. Conflict of interest and the public trust. J Am Med Assoc 284:2237.
21. Doher K. 2004. New human embryonic stem-cell lines to be made available to researchers. Howard Hughes Medical Institute News, March 3. (available at http://www.hhmi.org/news/melton4.html).
22. Dresser R. 2002. Embryonic stem cells: expanding the analysis. Am J Bioethics 2:40-41.
23. Exec Order No. 12, 591, 52 Fed Ref. (April 22, 1987)
24. Federal Technology Transfer Act Amendments, 1986
25. Gelijins AC, Their SO. 2002. Medical innovation and institutional interdependence: rethinking university-industry connections. J Am Med Assoc 287:1398-1399.
26. Geller G, Bernhartd MS, Holtzman NA. 2002. The media and public reaction to genetic research. J Am Med Assoc 287:773.
27. Henon PR. 2003. Human embryonic or adult stem cells: an overview on ethics and perspectives for tissue engineering. Adv Exp Med Biol 534:27-45.
28. Johns MME, Barnes M, Florencio PS. 2003. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest-promoting research while maintaining trust. J Am Med Assoc 289:741-746.
29. Kaiser J. 2004. Varmus backs some limits on NIH's consulting policy. Science 303:1749.
30. Kerrigan JE, Brasco CJ. 2002. The technology transfer revolution: legislative history and future proposals. Pub Cont Law J 31:277-291.
31. Leaf C. 2004. Why we're losing the war on cancer and how to win it. Fortune March 22:43-9.
32. Magill G. 2002. The ethics weave in human genomics, embryonic stem cell research, and therapeutic cloning: promoting and protecting society's interest. Alb Law Rev 65:701-728.
33. Mariani SM. 2003. Stem cells: a plenary policy forum. Medscape Gen Med 5:1.
34. McCrary SV, McCrary SV, Anderson CB, Jakovljevic J, Khan T, McCullough LB, Wray NP, Brody BA. 2000. A national survey of policies on disclosure of conflicts of interest in biomedical research. N Engl J Med 343:1621-1626.
35. McLaren A. 2001. Ethical and social considerations of stem cell research. Nature 414:129-131
36. Meyer JR. 2000. Human embryonic stem cells and respect for life. J Med Ethics 26:166-170.
37. Miller J. 2003. Comment: a call to legal arms: bringing embryonic stem cell therapies to market. 13 Alb Law J Sci Technol 555-592.
38. Moses H III, Martin JB. 2001. Academic relationships with industry: a new model for biomedical research. J Am Med Assoc 285:933-935.
39. Muscati SA. 2002. Some more humans than others: assessing the scope of patentability related to human embryonic stem cell research. J Law Sci Technol 4:201-227.
40. Nathan DG, Weatherall DJ. 2002. Academic freedom in clinical research. N Engl J Med 347:1368-1371.
41. National Bioethics Advisory Commission (NBAC). 1999. Ethical issues in Human Stem Cell Research. Volume I: Report and Recommendations of the National Bioethics Advisory Commission. September. (available at http://www.georgetown. edu/ research/nrcbl/nbacl/nbac.stem.pdf).
42. National Bioethics Advisory Commission (NBAC). 2000. Ethical issues in human stem cell research. Volume III: Religious perspectives. June. available at http://www.georgetown.edu/research/nrcbl/nbac/stemcell3.pdf).
43. National Institutes of Health. 1997. Guidelines for the Conduct of Research in the Intramural Research Programs at NIH. January. (available at http://www.nih.gov/news/irnews/guidelines.htm#anchor129022).
44. National Institutes of Health. 1998a. NIH Policy Manual Chapter 2300-735-1: Avoiding Conflicts of Interest. June 19. (available at http://ethics.od.nih.gov/chapters/735-1/735-1.pdf).
45. National Institutes of Health. 1998b. NIH Policy Manual Chapter 2300-735-4: Outside Work and Related Activities with Outside Organizations. February 17. (available at http://ethics.od.nih.gov/chapters/735-4/735-4.htm).
46. National Institutes of Health. 2000. Guidelines for Research Using Human Pluripotent Stem Cells. 65 Fed Reg 51,975 (Aug. 25, 2000), corrected as 65 Fed Reg 69,951 (Nov. 21, 2000).
47. National Institutes of Health. 2002. NIH Office of Extramural Research, Financial Conflict of Interest: Objectivity in Research. (available at http://grants2.nih.gov/grants/policy/coi/nih_review.htm).
48. Nature. 2001. Is the university-industrial complex out of control? Nature 409:119.
49. Newberg JA, Dunn RL. 2002. Keeping secrets in the campus lab: law, values and rules of engagement for industry-university R&D partnerships. Am Bus Law J 39:187240.
50. Noah L. 1998. Sanctifying scientific peer review: publication as a proxy for regulatory decision making. U Pitt Law Rev 59:677-717, Patent and Guidemark law Amendments, 1984.
51. Orr RD. 2002. The moral status of the embryonal stem cell: inherent or imputed? Am J Bioethics 2:57-59.
52. Patent and Trademark Law Amendments. 1984.
53. Perry D. 2000. Patient's voices: the powerful sound in the stem cell debate. Science 287:1423.
54. Philipkoski K. 2004. Need stem cells? We got 'em. Wired News, March 3. (available at http://www.wired.com/news/ medtech/0,1286,62513,00.html?tw= wn_story_related)
55. P.L. 101-99, 1996.
56. Powell K. 2002. US labs bemoan lack of stem cells. Nature 418:358.
57. President's Council on Bioethics. 2002. Human cloning and human dignity: an ethical inquiry. Washington: Public Affairs. October. (available at http://www.bioethics.gov/reports/cloningreport/index.html.
58. Rabino T. 2004. Stem cell and cloning controversies: human-genetics researchers tackle the issues. Gen Eng News 24:6-9.
59. Resnik DB. 2002. The commercialization of human stem cells: ethical and policy issues. Health Care Anal 10:127-154.
60. Tighe TT. 2003. Who's in charge of America's research universities? A blueprint for reform. State University of New York Press, Albany.
61. United States General Accounting Office (GAO). 2001. Biomedical Research: HHS Direction Needed to Address Financial Conflicts of Interest. November 26. (available at http://www.gao.gov/new.-items/d0289.pdf).
62. United States General Accounting Office (GAO). 2002. Federal Agency Efforts in Transferring and Reporting New Technology. October 31. (available at http://www.gao.gov/new.items/ d0347.pdf).
63. Verma IM. 2001. Are the benefits of stem cells being oversold? Mol Ther: J Am Soc Gene Therapy 4:161.
64. Weissman IL. 2002. Stem cells: scientific, medical, and political issues. N Engl J Med 346:1576-1579.
65. White House. 2001. Remarks by the President on Stem Cell Research [news release] and Fact Sheet on Embryonic Stem Cell Research, August 9. (available respectively at http://www.white-house.gov/news/releases/2001/08/20010809-1. html, and www.whitehouse.gov/news/releases/2001/08/20010S09-1.html).
66. Wong JF. 2004. Heated controversy continues over human cloning: confronting the philosophical issues. Gen Eng News 24:42.
67. Yoder MC Jr. 2001. Stem cells: preparing for the pitfalls that must inevitably precede the promise. J Hematother Stem Cell Res 10:579-580.